Innovacell Biotechnologie

Innovacell Biotechnologie AG is an innovative company with focus on cell therapy for the treatment of incontinence. Currently two personalised medical products are in development in multi-national clinical studies, ICES13 and ICEF15. Innovacell has also successfully developed proprietory injection technologies for the ultrasound guided implantation of sells into the target tissues. To date, more then 1,000 patients have been treated in nine clinical studies.